Reuters: Health
British drugmaker GSK applied on Friday for a license to market its HIV drug dolutegravir in a formulation designed to be easier for babies and children who are living with the virus to swallow.
GSK's ViiV seeks marketing license for baby-friendly HIV pill
GSK's ViiV seeks marketing license for baby-friendly HIV pill
Reuters: Health
British drugmaker GSK applied on Friday for a license to market its HIV drug dolutegravir in a formulation designed to be easier for babies and children who are living with the virus to swallow.
Reuters: Health
British drugmaker GSK applied on Friday for a license to market its HIV drug dolutegravir in a formulation designed to be easier for babies and children who are living with the virus to swallow.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment